| http://www.w3.org/ns/prov#value | - Nutra Pharma Announces ReceptoPharm Patent for a Method of Treating Multiple Sclerosis 11 April 2007 Nutra Pharma Corp. a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that its drug discovery division, ReceptoPharm, has filed a patent for a method of treating autoimmune diseases, including Multiple Sclerosis (MS) and Rheumatoid Arthritis.
|
